VC
GILD icon

Veery Capital’s Gilead Sciences GILD Stock Holding History

Veery Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Sell
2,330
-39
-2% -$5.14K 0.08% 75
2026
Q1 		$330K Sell
2,369
-52
-2% -$7.28K 0.1% 60
2025
Q4 		$297K Buy
2,421
+46
+2% +$5.59K 0.09% 67
2025
Q3 		$264K Sell
2,375
-76
-3% -$8.64K 0.08% 74
2025
Q2 		$272K Sell
2,451
-50
-2% -$5.32K 0.09% 66
2025
Q1 		$280K Buy
+2,501
New +$258K 0.11% 61

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Veery Capital's GILD Position: Q2 2026 in Review

Veery Capital reduced its Gilead Sciences (GILD) stake by 1.6% in Q2 2026, selling an estimated $5.14K and leaving 2,330 shares worth $294K. The position accounts for 0.08% of the portfolio, ranked #75.

Veery Capital first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $330K in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Veery Capital held 2,330 shares of Gilead Sciences worth $294K as of Q2 2026.
  • Veery Capital sold 39 Gilead Sciences shares in Q2 2026, an estimated $5.14K.
  • Gilead Sciences made up 0.08% of Veery Capital's portfolio in Q2 2026, its #75 holding.
  • Veery Capital first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Veery Capital's Gilead Sciences position peaked at $330K in Q1 2026.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Veery Capital's 13F filing for Q2 2026, filed 9 Jul 2026.